Aceso Life Science Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Millions HKD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Apr '26 Apr 28, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020 - 2016
Market Capitalization	1,001	369	1,174	1,314	472	1,574	Upgrade
Market Cap Growth	171.20%	-68.55%	-10.67%	178.13%	-69.98%	28.51%	Upgrade
PS Ratio	-17.87	-5.20	106.70	6.35	2.78	-12.20	Upgrade
PB Ratio	2.71	0.50	0.65	0.51	0.17	0.52	Upgrade
P/FCF Ratio	8.63	24.61	-	6.92	1.82	9.60	Upgrade
P/OCF Ratio	8.70	21.71	-	6.14	1.50	8.79	Upgrade
Debt / Equity Ratio	3.32	3.09	1.51	1.14	1.07	0.95	Upgrade
Debt / FCF Ratio	10.59	153.40	-	15.38	11.62	17.51	Upgrade
Net Debt / Equity Ratio	2.50	2.81	1.25	0.90	0.81	0.69	Upgrade
Net Debt / FCF Ratio	7.96	139.27	-47.27	12.21	8.85	12.72	Upgrade
Quick Ratio	1.87	0.26	0.56	0.49	0.73	1.49	Upgrade
Current Ratio	1.98	0.28	0.57	0.70	0.93	1.93	Upgrade
Asset Turnover	-	-	0.00	0.03	0.03	-	Upgrade
Return on Equity (ROE)	-51.44%	-79.55%	-36.87%	-7.70%	-20.41%	-12.63%	Upgrade
Return on Assets (ROA)	-16.94%	-25.33%	-14.59%	-3.31%	-9.59%	-6.21%	Upgrade
Return on Invested Capital (ROIC)	-19.21%	-7.64%	-4.46%	-1.59%	-2.32%	-8.67%	Upgrade
Earnings Yield	-37.16%	-242.49%	-39.36%	-20.09%	-78.32%	-23.89%	Upgrade
FCF Yield	11.59%	4.06%	-4.09%	14.46%	54.82%	10.42%	Upgrade
Buyback Yield / Dilution	-0.98%	1.06%	0.60%	1.63%	-6.06%	-21.39%	Upgrade

Source: S&P Capital IQ. Financial Services template. Financial Sources.